Tobacco Companies Knew Nicotine Was Addictive in 1963. It Took Until 2009 for the FDA to Regulate It. Here’s What Happened in Between.

The knowledge existed from the beginning. What took 46 years was something else entirely.

In 1963, a senior researcher at Brown & Williamson (one of the largest tobacco companies in the United States) wrote an internal memo that should have changed everything.

It read, with a clarity that is almost shocking in retrospect:

“Nicotine is addictive. We are, then, in the business of selling nicotine, an addictive drug.”

The memo was not published. It was not submitted to any regulatory body. It was not shared with the Surgeon General, who was at that very moment assembling the team that would produce the landmark 1964 Report on Smoking and Health, the document that would formally declare cigarettes a cause of cancer and trigger decades of public health response.

The memo was filed away.

It would remain buried for thirty years.

What 1964 Did and Did Not Change

The Surgeon General’s report was a genuine watershed. It represented the first time the United States government formally acknowledged, in an official document, that cigarettes caused lung cancer and were a serious public health hazard.

The industry responded with a strategy that has since become a template.

It did not deny. It complicated.

Within months of the report’s publication, the tobacco industry had established the Tobacco Industry Research Committee- a body whose stated purpose was scientific inquiry, and whose actual purpose was the production of uncertainty. Not answers. Uncertainty. The goal was never to disprove the science. The goal was to ensure that the science never felt fully settled, that there was always another study to wait for, always another expert willing to say the picture was more complicated than it appeared.

This distinction between denying science and manufacturing doubt about it, is one of the most important and underappreciated tactics in the history of corporate accountability avoidance. It is more sophisticated than denial. It is harder to fight. And it worked for decades.

Meanwhile, the internal research continued. Quietly. Carefully. And with increasing precision, it kept confirming what the 1963 memo had already concluded.

The companies knew. They kept knowing. And they kept not saying.

The 1994 Moment

For many people, the most viscerally memorable chapter of this story is a single day in April 1994.

Seven tobacco company CEOs sat before the House Subcommittee on Health and the Environment. Under oath. On camera. Facing a direct question about whether they believed nicotine was addictive.

One by one, all seven said NO.

The documents proving the opposite already existed. Some were already in the process of leaking, a paralegal named Merrell Williams had spent years quietly photocopying internal Brown & Williamson documents and passing them to a plaintiff’s attorney. The industry knew the dam was cracking.

They testified anyway.

The footage is available on YouTube. It is worth watching not because it is surprising but because it is instructive. These were not rogue actors. These were the chief executives of some of the most profitable companies in American history, coordinating a position they knew to be false, in front of a congressional committee, because the alternative (admission) would have been legally and financially catastrophic.

This is what an industry defending itself against accountability looks like at full deployment.

The FDA Tries. The Supreme Court Says No.

In 1994, emboldened by the congressional hearings and the growing documentary record, the FDA under Commissioner David Kessler began building a regulatory case. Kessler’s argument was straightforward: nicotine is a drug, cigarettes are drug delivery devices, and the FDA therefore has jurisdiction over them under the Food, Drug, and Cosmetic Act.

It was a logical argument. It was also, ultimately, a losing one.

In 2000, the Supreme Court ruled 5-4 against the FDA in FDA vs Brown & Williamson Tobacco Corp. The majority opinion contained a passage that deserves to be read carefully by anyone interested in how law can become an instrument of paralysis:

The Court ruled that Congress had never explicitly granted the FDA authority over tobacco, and that this was deliberate, because if the FDA did have that authority, it would be legally obligated to ban tobacco outright as an unsafe product. Since Congress had clearly never intended to ban tobacco, it could not have intended to give the FDA authority over it.

Read that again slowly.

A product that kills approximately half of its long-term users, a product whose own manufacturers had internally documented as a vehicle for delivering an addictive drug- could not be regulated by the agency responsible for drug safety, because regulating it properly would have required banning it, and banning it was considered politically impossible.

The product existed in a category of its own. Not food. Not drug. Not device. Not cosmetic. Nothing. A legal nowhere. An intentional blind spot at the center of the American regulatory state.

The industry had not just defeated regulation. It had engineered a legal architecture in which regulation was structurally unavailable.

What Filled the 46 Years

Between 1963 and 2009, the following things happened:

An estimated 10 million Americans died from smoking-related illness. Globally, the World Health Organization estimates that tobacco killed approximately 100 million people in the 20th century alone.

The industry spent hundreds of millions of dollars on research designed not to find answers but to prevent them from being found. It funded scientists whose role was not discovery but contestation. It created institutional infrastructure (think tanks, research committees, academic relationships) whose function was to ensure that scientific consensus on tobacco harm remained perpetually just beyond reach.

It lobbied every session of Congress. It cultivated relationships with legislators in tobacco-growing states, like Virginia, North Carolina, Kentucky, for whom the industry was not an abstraction but the economic foundation of their constituencies. It donated to campaigns on both sides of the aisle with enough consistency that no durable political coalition in favor of regulation could ever be assembled without cost.

It negotiated the language of warning labels. The Surgeon General’s warning that appears on every cigarette pack in the United States was not written exclusively by public health advocates. Its language was negotiated- a compromise between what the science demanded and what the industry would accept. The warning has not changed meaningfully in sixty years.

It fought every proposed restriction on flavors, advertising, and marketing. Not always to win outright though it won often, but to delay. Delay was itself the product. Every year of regulatory delay was worth billions in revenue from customers who might otherwise have had more information, fewer options to start, or better options to stop.

And through all of it, internally, the science kept accumulating. The companies knew more about nicotine addiction, about the pharmacology of their products, about the specific mechanisms by which their engineering decisions increased addictive potential, than most of the regulators trying to govern them.

The knowledge was never the problem.

2009: The Act That Arrived 46 Years Late

The Family Smoking Prevention and Tobacco Control Act was signed into law by President Obama on June 22, 2009. It gave the FDA authority over the manufacture, distribution, and marketing of tobacco products for the first time in American history.

It was a genuine milestone. It was also, by any reasonable measure, 46 years late.

And even the 2009 Act did not resolve everything. The question of menthol (the flavor additive that numbs the airways, eases the harshness of early cigarette use, and dramatically aids the recruitment of new smokers) was not settled. The FDA announced a proposed rule to ban menthol cigarettes in 2022. The industry’s legal and lobbying response was immediate, sustained, and it succeeded in 2025 when the Trump administration withdrew the proposed rules to ban menthol cigarettes on January 21, 2025.

The game continues. The playbook is the same.

This Is Not Ancient History

It would be comfortable to read this story as a historical curiosity as a cautionary tale from a less enlightened era, before we understood how regulatory capture worked, before we had the tools to see industry strategy for what it was.

It is not a historical curiosity.

The tobacco industry’s approach to managing the threat of accountability (fund doubt, manufacture uncertainty, lobby both sides, negotiate the language of the regulations meant to govern you, and above all delay) did not die with the cigarette’s cultural moment. It was exported.

The sugar industry used it when research began linking sucrose consumption to obesity and metabolic disease. The opioid industry used it when the addiction profile of OxyContin began to become visible. The fossil fuel industry used it, and continues to use it, with a sophistication that reflects decades of study of the tobacco precedent. The tobacco industry continues to use it for nicotine pouches and vapes.

When historians of corporate accountability write about the 20th century, tobacco will be understood not just as a public health catastrophe but as a school. It taught the most important lesson available to an industry facing an existential accountability threat: you do not need to win the scientific argument. You only need to prevent it from being resolved long enough to protect the revenue cycle.

That lesson has been learned. It is being applied right now.

The Question Worth Sitting With

Understanding the tobacco regulatory timeline is not an academic exercise for public health professionals and policy historians.

It is a live diagnostic tool.

Every time a powerful industry faces credible evidence that its products cause harm and responds not with transparency but with funded research, lobbying, and the strategic deployment of uncertainty, the tobacco playbook is in operation. The industry fights on its strongest terrain- lobbying, litigation, regulatory capture, and campaign finance. Public health has tried to match that for decades and keeps losing ground. The deeper structural problem is that public health operates on a logic of evidence and consensus. The tobacco industry operates on a logic of delay. Every year the ban doesn’t happen is a year of revenue. They don’t need to win the scientific argument, they just need to slow the policy response long enough to extract value. Public health has never fully reckoned with that asymmetry.

So the question is not why it took 46 years for the FDA to regulate tobacco.

The question is: what are we allowing to take that long today?

And more specifically: what will the equivalent of that 1963 memo look like when it finally surfaces and what will it cost that we already had it, and looked the other way?

— — — — — — — — — — — — — — — — — — — — — — — — — — — —

This piece is part of an ongoing series examining the structural and corporate dimensions of tobacco, nicotine, and addiction moving the conversation beyond individual behavior toward the systems and strategies that manufactured the problem in the first place. If it was useful, share it with someone working at the intersection of public health, policy, or corporate accountability.